CEFAZOLIN IN DEXTROSE (CEFAZOLIN SODIUM) — FDA Approval NDA207131 (BAXTER HLTHCARE CORP)
CEFAZOLIN IN DEXTROSE (CEFAZOLIN SODIUM) — FDA Approval NDA207131 (BAXTER HLTHCARE CORP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEFAZOLIN IN DEXTROSE; Active ingredients: CEFAZOLIN SODIUM; Application number: NDA207131.
| Brand name | CEFAZOLIN IN DEXTROSE |
|---|---|
| Active ingredients | CEFAZOLIN SODIUM |
| Application number | NDA207131 |
| Sponsor | BAXTER HLTHCARE CORP |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20150807 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →